Terumo Future Growth
Future criteria checks 2/6
Terumo is forecast to grow earnings and revenue by 12.1% and 5.8% per annum respectively. EPS is expected to grow by 12.4% per annum. Return on equity is forecast to be 11.1% in 3 years.
Key information
12.1%
Earnings growth rate
12.4%
EPS growth rate
Medical Equipment earnings growth | 0% |
Revenue growth rate | 5.8% |
Future return on equity | 11.1% |
Analyst coverage | Good |
Last updated | 22 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 1,170,253 | 172,064 | 124,780 | 222,922 | 14 |
3/31/2026 | 1,090,644 | 152,151 | 109,870 | 206,874 | 15 |
3/31/2025 | 1,020,231 | 130,713 | 85,218 | 161,661 | 13 |
9/30/2024 | 986,674 | 119,486 | 114,170 | 193,649 | N/A |
6/30/2024 | 964,805 | 117,716 | 92,134 | 170,598 | N/A |
3/31/2024 | 921,863 | 106,374 | 67,556 | 146,330 | N/A |
12/31/2023 | 885,167 | 99,042 | 60,490 | 133,870 | N/A |
9/30/2023 | 860,767 | 99,096 | 35,316 | 110,769 | N/A |
6/30/2023 | 838,121 | 89,476 | 30,037 | 105,606 | N/A |
3/31/2023 | 820,209 | 89,325 | 45,363 | 117,536 | N/A |
12/31/2022 | 797,814 | 87,297 | 47,491 | 117,976 | N/A |
9/30/2022 | 761,982 | 79,146 | 65,356 | 135,078 | N/A |
6/30/2022 | 728,927 | 83,316 | 65,052 | 134,924 | N/A |
3/31/2022 | 703,303 | 88,813 | 67,362 | 141,467 | N/A |
12/31/2021 | 688,696 | 90,363 | 69,610 | 146,371 | N/A |
9/30/2021 | 675,183 | 95,414 | 69,307 | 146,611 | N/A |
6/30/2021 | 654,260 | 91,161 | 53,415 | 133,980 | N/A |
3/31/2021 | 613,842 | 77,268 | 38,573 | 121,485 | N/A |
12/31/2020 | 607,381 | 76,919 | 27,594 | 117,626 | N/A |
9/30/2020 | 604,915 | 71,342 | 20,121 | 109,392 | N/A |
6/30/2020 | 607,669 | 76,422 | 28,116 | 115,667 | N/A |
3/31/2020 | 628,897 | 85,211 | 33,995 | 117,479 | N/A |
12/31/2019 | 626,016 | 89,868 | 35,756 | 109,420 | N/A |
9/30/2019 | 621,762 | 90,727 | 34,047 | 104,160 | N/A |
6/30/2019 | 608,987 | 84,170 | 38,464 | 100,340 | N/A |
3/31/2019 | 599,481 | 79,470 | 39,207 | 93,571 | N/A |
12/31/2018 | 594,429 | 84,305 | N/A | N/A | N/A |
9/30/2018 | 588,162 | 92,782 | 61,609 | 106,706 | N/A |
6/30/2018 | 591,483 | 93,095 | N/A | N/A | N/A |
3/31/2018 | 587,775 | 91,295 | N/A | 114,562 | N/A |
12/31/2017 | 576,725 | 85,888 | N/A | N/A | N/A |
9/30/2017 | 553,664 | 66,769 | N/A | 87,995 | N/A |
6/30/2017 | 528,957 | 60,406 | N/A | N/A | N/A |
3/31/2017 | 514,164 | 54,225 | N/A | 80,862 | N/A |
12/31/2016 | 503,429 | 39,014 | N/A | N/A | N/A |
9/30/2016 | 510,969 | 44,087 | N/A | 85,463 | N/A |
6/30/2016 | 520,885 | 46,282 | N/A | N/A | N/A |
3/31/2016 | 525,026 | 50,676 | N/A | 80,303 | N/A |
12/31/2015 | 522,296 | 48,528 | N/A | N/A | N/A |
9/30/2015 | 515,364 | 43,603 | N/A | 80,102 | N/A |
6/30/2015 | 503,221 | 44,580 | N/A | N/A | N/A |
3/31/2015 | 489,506 | 38,470 | N/A | 73,110 | N/A |
12/31/2014 | 485,301 | 30,626 | N/A | N/A | N/A |
9/30/2014 | 474,640 | 36,517 | N/A | 86,298 | N/A |
6/30/2014 | 471,214 | 33,534 | N/A | N/A | N/A |
3/31/2014 | 467,360 | 34,096 | N/A | 96,260 | N/A |
12/31/2013 | 451,805 | 59,203 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4543 N's forecast earnings growth (12.1% per year) is above the savings rate (8.1%).
Earnings vs Market: 4543 N's earnings (12.1% per year) are forecast to grow faster than the MX market (11.5% per year).
High Growth Earnings: 4543 N's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4543 N's revenue (5.8% per year) is forecast to grow slower than the MX market (7.2% per year).
High Growth Revenue: 4543 N's revenue (5.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4543 N's Return on Equity is forecast to be low in 3 years time (11.1%).